EBPA-FIBROGEN INTERACTION IN ENTEROCOCCUS FAECALIS CAUTI
粪肠球菌中 EBPA-纤维原的相互作用
基本信息
- 批准号:8901925
- 负责人:
- 金额:$ 38.13万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2014
- 资助国家:美国
- 起止时间:2014-08-01 至 2018-07-31
- 项目状态:已结题
- 来源:
- 关键词:AddressAdherenceAdhesivesAnimalsAntibiotic ResistanceAntibioticsAntibodiesAntibody ResponseBacteremiaBacteriaBacterial AdhesinsBindingBiogenesisBiological AssayBiologyBladderBladder TissueBlocking AntibodiesCathetersCessation of lifeCollaborationsDataDevelopmentDiseaseDrug FormulationsEndocarditisEnterococcus faecalisEpitheliumFibrinogenGenesGrowthHairHealthImmunityImmunizationImmunotherapyIn VitroInfectionInflammatory ResponseInterferometryKineticsLeadLigand BindingMicrobial BiofilmsModalityModelingMolecularMolecular AnalysisMusMutagenesisNosocomial InfectionsNutritional RequirementsPassive ImmunizationPathogenesisPatientsPeptide VaccinesPeptidesPilumPlatinumProliferatingProtein RegionProteinsResistanceSerumSiliconesSite-Directed MutagenesisSpecificityTestingTherapeutic AgentsThermodynamicsTubeUrethraUrinary CatheterizationUrinary tractUrinary tract infectionUrineVaccinesVirulencealternative treatmentappendagebacterial resistancebasecatheter associated UTIdirect applicationhuman diseaseimplantationin vitro Assayin vivoinsightinterdisciplinary approachmouse modelmutantnovelnovel therapeuticspreventprotective efficacy
项目摘要
DESCRIPTION (provided by applicant): Catheter-associated urinary tract infections (CAUTIs) are one of the most common nosocomial infections and if untreated can lead to serious complications including bacteremia and death. Enterococcus faecalis is a leading causative agent of CAUTI and its ability to adhere and persist within the host along with its multiple antibiotic resistances makes it difficult to prevent and treat. Furthermore, E. faecalis can form biofilm and grow despite a robust inflammatory response during CAUTI. The molecular details of how E. faecalis adheres, grows in the bladder, forms biofilm and the importance of biofilm in persistence in CAUTI are not well understood. This project will use a recently optimized model of E. faecalis CAUTI to understand how interactions between the E. faecalis Epb pilus and fibrinogen contribute to disease. Important questions to be addressed include a molecular analysis of how the EbpA subunit of the pilus binds to fibrinogen and the importance of this interaction to CAUTI. Mutants defective for biofilm formation in vitro are fully capable of forming
biofilm in murine CAUTI, suggesting that standard biofilm models do not reproduce relevant in vivo conditions. This project will evaluate a new model of fibrinogen-supplemented urine biofilms to determine if genes required for biofilm in this model are also required for biofilm in murine CAUTI and will test the importance of biofilm in causing disease. Finally, we have data to suggest that an EbpA subunit-based vaccine protects against murine CAUTI and that immunized animals generate antibody that blocks EbpA-fibrinogen binding. The project will test the protective efficacy of various EbpA sub-domain and peptide vaccines in comparison to formulations that use other pilus sub- units. Combined with passive transfers of sera from immunized animals and characterization of antibody responses, it will be possible to specifically test whether the mechanism of protection depends on blocking EbpA-fibrinogen binding. The data generated by this project will provide significant new insights into the pathogenesis of CAUTI with direct application to the development of new modalities of therapy. .
描述(由申请人提供):导管相关性尿路感染(CAUTIs)是最常见的医院感染之一,如果不进行治疗,可能会导致严重的并发症,包括菌血症和死亡。粪肠球菌是CAUTI的主要病原体,其在宿主体内的粘附性和持久性以及多重耐药性使其难以预防和治疗。此外,粪肠球菌可以形成生物膜并生长,尽管在CAUTI期间有强烈的炎症反应。粪肠球菌如何附着、在膀胱中生长、形成生物膜以及生物膜在CAUTI中持续存在的重要性等分子细节尚不清楚。这个项目将使用最近优化的粪肠球菌模型来了解粪肠球菌EPB菌毛和纤维蛋白原之间的相互作用如何导致疾病。需要解决的重要问题包括对毛孔的EBPA亚单位如何与纤维蛋白原结合的分子分析,以及这种相互作用对CAUTI的重要性。体外生物膜形成缺陷突变株完全有能力形成
在小鼠CAUTI中的生物膜,表明标准的生物膜模型不能在体内复制相关的条件。该项目将评估一种新的添加纤维蛋白原的尿液生物膜模型,以确定该模型中生物膜所需的基因是否也是小鼠CAUTI生物膜所必需的,并将测试生物膜在致病中的重要性。最后,我们有数据表明,基于EBPA亚单位的疫苗可以预防小鼠CAUTI,并且免疫的动物会产生阻断EBPA-纤维蛋白原结合的抗体。该项目将测试各种EBPA亚域和多肽疫苗的保护效力,并与使用其他菌毛亚单位的制剂进行比较。结合被动转移免疫动物的血清和抗体反应的特征,将有可能具体测试保护机制是否依赖于阻断EBPA-纤维蛋白原结合。该项目产生的数据将为CAUTI的发病机制提供重要的新见解,并直接应用于开发新的治疗方式。。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Michael G. Caparon其他文献
Volatile profiling distinguishes emStreptococcus pyogenes/em from other respiratory streptococcal species
挥发性分析区分化脓性链球菌和其他呼吸道链球菌物种
- DOI:
10.1128/msphere.00194-23 - 发表时间:
2023-09-28 - 期刊:
- 影响因子:3.100
- 作者:
Amalia Z. Berna;Joseph A. Merriman;Leah Mellett;Danealle K. Parchment;Michael G. Caparon;Audrey R. Odom John;Jacqueline M. Achkar - 通讯作者:
Jacqueline M. Achkar
Streptococcus pyogenes protein F promotes invasion of HeLa cells.
化脓性链球菌蛋白 F 促进 HeLa 细胞的侵袭。
- DOI:
10.1099/00221287-144-11-3079 - 发表时间:
1998 - 期刊:
- 影响因子:1.5
- 作者:
Nobuhiko Okada;lchiro Tatsuno;Emanuel Hanski;Michael G. Caparon;C. Sasakawa - 通讯作者:
C. Sasakawa
Reprogramming aerobic metabolism mitigates Streptococcus pyogenes tissue damage in a mouse necrotizing skin infection model
在小鼠坏死性皮肤感染模型中,重新编程有氧代谢可减轻化脓性链球菌组织损伤。
- DOI:
10.1038/s41467-025-57348-x - 发表时间:
2025-03-15 - 期刊:
- 影响因子:15.700
- 作者:
Wei Xu;Tara R. Bradstreet;Zongsen Zou;Suzanne Hickerson;Yuan Zhou;Hongwu He;Brian T. Edelson;Michael G. Caparon - 通讯作者:
Michael G. Caparon
MP23-19 FIBRINOGEN DEPOSITS ON URINARY CATHETERS IN A TIME-DEPENDENT MATTER AND CO-LOCALIZES WITH <em>E. FAECALIS</em> IN PATIENTS WITH POSITIVE <em>E. FAECALIS</em> URINE CULTURES
- DOI:
10.1016/j.juro.2017.02.747 - 发表时间:
2017-04-01 - 期刊:
- 影响因子:
- 作者:
Tyler M. Bauman;Aaron M. Potretzke;Ana L. Flores-Mireles;Jennifer N. Walker;Alyssa M. Park;Henry L. Schreiber;Jerome S. Pinkner;Michael G. Caparon;Scott J. Hultgren;Alana Desai - 通讯作者:
Alana Desai
Michael G. Caparon的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Michael G. Caparon', 18)}}的其他基金
Novel Therapeutic Approach to Invasive Group A Streptococcal Disease
侵袭性 A 组链球菌疾病的新治疗方法
- 批准号:
10452033 - 财政年份:2022
- 资助金额:
$ 38.13万 - 项目类别:
Novel Therapeutic Approach to Invasive Group A Streptococcal Disease
侵袭性 A 组链球菌疾病的新治疗方法
- 批准号:
10546470 - 财政年份:2022
- 资助金额:
$ 38.13万 - 项目类别:
Characterization of assembly factors for type IV secretion systems
IV 型分泌系统组装因子的表征
- 批准号:
10435561 - 财政年份:2021
- 资助金额:
$ 38.13万 - 项目类别:
GmPcides: Componds that disarm antibiotic resistance in multiple gram-positive pathogens
GmPcides:解除多种革兰氏阳性病原体抗生素耐药性的化合物
- 批准号:
10577811 - 财政年份:2021
- 资助金额:
$ 38.13万 - 项目类别:
GmPcides: Componds that disarm antibiotic resistance in multiple gram-positive pathogens
GmPcides:解除多种革兰氏阳性病原体抗生素耐药性的化合物
- 批准号:
10162829 - 财政年份:2021
- 资助金额:
$ 38.13万 - 项目类别:
GmPcides: Componds that disarm antibiotic resistance in multiple gram-positive pathogens
GmPcides:解除多种革兰氏阳性病原体抗生素耐药性的化合物
- 批准号:
10352471 - 财政年份:2021
- 资助金额:
$ 38.13万 - 项目类别:
Structure-function analysis of type IVB secretion systems
IVB型分泌系统的结构-功能分析
- 批准号:
10624264 - 财政年份:2019
- 资助金额:
$ 38.13万 - 项目类别:
EBPA-FIBROGEN INTERACTION IN ENTEROCOCCUS FAECALIS CAUTI
粪肠球菌中 EBPA-纤维原的相互作用
- 批准号:
9304949 - 财政年份:2014
- 资助金额:
$ 38.13万 - 项目类别:
EBPA-FIBROGEN INTERACTION IN ENTEROCOCCUS FAECALIS CAUTI
粪肠球菌中 EBPA-纤维原的相互作用
- 批准号:
8759401 - 财政年份:2014
- 资助金额:
$ 38.13万 - 项目类别:
CATABOLITE REPRESSION CONTROLS VIRULENCE IN STREPTOCOCCUS PYOGENES
分解代谢物抑制控制化脓性链球菌的毒力
- 批准号:
9174072 - 财政年份:2007
- 资助金额:
$ 38.13万 - 项目类别:
相似海外基金
An innovative, AI-driven prehabilitation platform that increases adherence, enhances post-treatment outcomes by at least 50%, and provides cost savings of 95%.
%20创新、%20AI驱动%20康复%20平台%20%20增加%20依从性、%20增强%20治疗后%20结果%20by%20at%20至少%2050%、%20和%20提供%20成本%20节省%20of%2095%
- 批准号:
10057526 - 财政年份:2023
- 资助金额:
$ 38.13万 - 项目类别:
Grant for R&D
Improving Repositioning Adherence in Home Care: Supporting Pressure Injury Care and Prevention
提高家庭护理中的重新定位依从性:支持压力损伤护理和预防
- 批准号:
490105 - 财政年份:2023
- 资助金额:
$ 38.13万 - 项目类别:
Operating Grants
I-Corps: Medication Adherence System
I-Corps:药物依从性系统
- 批准号:
2325465 - 财政年份:2023
- 资助金额:
$ 38.13万 - 项目类别:
Standard Grant
Unintrusive Pediatric Logging Orthotic Adherence Device: UPLOAD
非侵入式儿科记录矫形器粘附装置:上传
- 批准号:
10821172 - 财政年份:2023
- 资助金额:
$ 38.13万 - 项目类别:
Nuestro Sueno: Cultural Adaptation of a Couples Intervention to Improve PAP Adherence and Sleep Health Among Latino Couples with Implications for Alzheimer’s Disease Risk
Nuestro Sueno:夫妻干预措施的文化适应,以改善拉丁裔夫妇的 PAP 依从性和睡眠健康,对阿尔茨海默病风险产生影响
- 批准号:
10766947 - 财政年份:2023
- 资助金额:
$ 38.13万 - 项目类别:
CO-LEADER: Intervention to Improve Patient-Provider Communication and Medication Adherence among Patients with Systemic Lupus Erythematosus
共同领导者:改善系统性红斑狼疮患者的医患沟通和药物依从性的干预措施
- 批准号:
10772887 - 财政年份:2023
- 资助金额:
$ 38.13万 - 项目类别:
Pharmacy-led Transitions of Care Intervention to Address System-Level Barriers and Improve Medication Adherence in Socioeconomically Disadvantaged Populations
药房主导的护理干预转型,以解决系统层面的障碍并提高社会经济弱势群体的药物依从性
- 批准号:
10594350 - 财政年份:2023
- 资助金额:
$ 38.13万 - 项目类别:
Antiretroviral therapy adherence and exploratory proteomics in virally suppressed people with HIV and stroke
病毒抑制的艾滋病毒和中风患者的抗逆转录病毒治疗依从性和探索性蛋白质组学
- 批准号:
10748465 - 财政年份:2023
- 资助金额:
$ 38.13万 - 项目类别:
Improving medication adherence and disease control for patients with multimorbidity: the role of price transparency tools
提高多病患者的药物依从性和疾病控制:价格透明度工具的作用
- 批准号:
10591441 - 财政年份:2023
- 资助金额:
$ 38.13万 - 项目类别:
Development and implementation of peer-facilitated decision-making and referral support to increase uptake and adherence to HIV pre-exposure prophylaxis in African Caribbean and Black communities in Ontario
制定和实施同行协助决策和转介支持,以提高非洲加勒比地区和安大略省黑人社区对艾滋病毒暴露前预防的接受和依从性
- 批准号:
491109 - 财政年份:2023
- 资助金额:
$ 38.13万 - 项目类别:
Fellowship Programs